The North American Educational Forum on Lymphoma will be a virtual program to deliver live patient education programming during the COVID-19 pandemic. The program provided access to lymphoma experts, accessible online. Please continue to check this page for updates. For updates on digital and rescheduled programs, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation.
VIRTUAL – 2022 North American Educational Forum on Lymphoma
DATE: October 28 – 30, 2022
VIRTUAL PROGRAM – This is a virtual event, only accessible online. Access instructions will be provided before event date.
This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.
Program Agenda
Friday, October 28, 2022 – All times ET
11:45 AM ET Welcome and LRF Opening Remarks – Sarah Quinlan, Lymphoma Research Foundation
12:00 PM Introductory Breakouts (choose one)
- Lymphoma Overview for Newly Diagnosed Patients – Victor Orellana-Noia, MD, Emory University
- How to Cope When Your Lymphoma Returns and Finding the Next Treatment Option – Raphael Steiner, MD, MD Anderson Cancer Center
- Managing Quality of Life During Survivorship – Tara Henderson, MD, MPH, University of Chicago
- Caring for a Loved One with Lymphoma – Kelly Shaffer, PhD, University of Virginia
1:00 PM Explore Exhibit Hall and Networking Lounge
1:30 PM Living with Lymphoma Breakout Sessions (choose one)
- How Should Telehealth Be Used and Best Practices – Brian Link, MD, University of Iowa
- What You Should Know About Managing Pain and Symptom Care – Hamza Habib, MD, Rutgers University of New Jersey
- Shared Decision Making When Talking with Your Healthcare Team about Treatment Plan – Susan Parsons, MD, MRP, Tufts University
- Avoiding Financial Toxicity and Hardships – Joanna Morales, Esq., Triage Cancer
2:30 PM Integrative Health and Complimentary Treatments
- Sandy Colvard, ND, FABNO, University of California, Irvine
Saturday, October 29, 2022 – All times ET
10:00 AM – 10:30 AM Explore Exhibit Hall and Networking Lounge
10:30 AM – 11:00 AM ET Emerging Lymphoma Treatments on the Horizon
- John Timmerman, MD, University of California, Los Angeles
11:00 AM – 11:30 AM Updates on COVID-19
- Leo Gordon, MD, Northwestern University
11:30 AM – 12:00 PM Question and Answer Panel
- John Timmerman, MD, UCLA and Leo Gordon, MD, Northwestern University
12:00 PM – 12:30 PM Explore Exhibit Hall and Networking Lounge
12:30 PM – 1:30 PM Disease-Specific Breakout Sessions – B-Cell Lymphomas (choose one)
- Burkitt Lymphoma – Suchitra Sundaram, MD, Icahn School of Medicine at Mount Sinai
- Primary Central Nervous System Lymphoma – James Rubenstein, MD, University of California, San Francisco
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma – Jennifer Brown, MD, Dana-Farber Cancer Institute
- Diffuse Large B-Cell Lymphoma / Other Aggressive B-Cell Lymphomas (Double and Triple Hit) – Thomas Habermann, MD, Mayo Clinic, Rochester, MN
- Follicular Lymphoma: Newly Diagnosed – Jonathan Friedberg, MD, University of Rochester, NY
- Hodgkin Lymphoma: Newly Diagnosed – Ann LaCasce, MD, Dana-Farber Cancer Institute
- Mantle Cell Lymphoma: Newly Diagnosed – Tim Fenske, MD, Medical College of Wisconsin
- Splenic Marginal Zone Extranodal MALT and Nodal Marginal Zone Lymphoma – Izidore Lossos, MD, University of Miami
- Waldenstrom Macroglobulinemia – Shuo Ma, MD, Northwestern University
12:30 PM – 1:30 PM Plenary Session: Navigating the Complexities of T-Cell Lymphoma
- Steve Horwitz, MD, Memorial Sloan Kettering Cancer Center
1:30 PM – 1:45 PM Explore Exhibit Hall and Networking Lounge
1:45 PM – 2:45 PM Patients and Physicians Panel Discussion: Overview and Update on Cellular Therapies
- Ed Forum Chairs and LRF Ambassadors/Patients
2:45 PM – 3:00 PM Explore Exhibit Hall and Networking Lounge
3:00 PM – 4:00 PM Disease-Specific Breakout Sessions – Relapsed/Refractory B-Cell Lymphomas (choose one)
- CLL / SLL – Anthony Mato, MD, Memorial Sloan Kettering Cancer Center
- Diffuse Large B-Cell Lymphoma and Other Aggressive Lymphomas – Laurie Sehn, MD, MPH, University of British Columbia
- Hodgkin Lymphoma – Ryan Lynch, MD, University of Washington
- Follicular Lymphoma – Bruce Cheson, MD, FACP, FAAAS, FASCO, Scientific Advisor, LRF
- Mantle Cell Lymphoma – Kami Maddocks, MD, The Ohio State University
3:00 PM – 4:00 PM Disease-Specific Breakout Sessions – T-Cell Lymphomas (choose one)
- Anaplastic Large Cell Lymphoma – Kerry Savage, MD, British Columbia Cancer Agency
- Angioimmunoblastic T-Cell Lymphoma – Bradley Haverkos, MD, University of Colorado
- Cutaneous T-Cell Lymphomas – Pamela Allen, MD, Emory University
- Peripheral T-Cell Lymphoma NOS – Pierluigi Porcu, MD, Jefferson University Hospitals
- Rare T-Cell Lymphomas – Neha Mehta-Shah, MD, Washington University in St. Louis
4:00 PM – 4:15 PM Explore Exhibit Hall and Networking Lounge
4:15 PM – 5:15 PM Special Lymphoma Breakout Topics: Part I (choose one)
- MRD in all Lymphomas – Elizabeth Brem, MD, University of California, Irvine
- Treatment Options for Transformed Lymphomas – Loretta Nastoupil, MD, MD Anderson Cancer Center
- CAR T Cell Therapy – Jeremy Abramson, MD, Massachusetts General Hospital
- Oral Therapies: Access and Toxicity – Craig Portell, MD, University of Virginia
- Caregivers Support Group – Sarah Paul, LCSW, OSW-C, CancerCare
Sunday, October 30, 2022 – All times ET
9:30 AM – 10:00 AM Explore Exhibit Hall and Networking Lounge
10:00 AM – 11:00 AM Nutrition: Staying Healthy During and After Treatment – Holly Mills, RD, CSO, John Theurer Cancer Center, Hackensack University Medical Center
11:00 AM – 11:15 AM Explore Exhibit Hall and Networking Lounge
11:15 AM – 12:15 PM Special Lymphoma Breakout Topics: Part II (choose one)
- Diagnosing Lymphoma with Diagnostic and Biomarker Testing – Lisa Rimsza, MD, Mayo Clinic, Phoenix, AZ
- Coping with Lymphoma as an Adolescent and Young Adult (AYA) – Sharon Castellino, MD, Emory University
- Surveillance Strategies: I’ve Finished My Treatment. What Comes Next? – Carrie Thompson, MD, Mayo Clinic, Rochester, MN
- Immunotherapy : Beyond CAR T Cell Therapy – Manali Kamdar, MD, University of Colorado
12:15 PM – 12:30 PM Explore Exhibit Hall and Networking Lounge
12:30 PM – 1:30 PM Lymphoma Research Update: Mantle Cell, Follicular and AYA
- Andrew Evens, DO, Rutgers Cancer Institute of New Jersey
- Eduardo Sotomayor, MD, Cancer Center of South Florida
- Sonali Smith, MD, University of Chicago
- overview
- register & VIEW PROGRAM
- agenda
- partners
- SUPPORTERS